Remifentanil for fetal immobilization and analgesia during the ex utero intrapartum treatment procedure under combined spinalepidural anaesthesia

Ryan Fink, T. K. Allen, A. S. Habib

Research output: Contribution to journalArticle

17 Scopus citations


Remifentanil undergoes extensive placental transfer and has been used to provide fetal immobilization and anaesthesia for in utero fetal endoscopic interventions. We report three cases of the ex utero intrapartum treatment performed under neuraxial anaesthesia where the maternal administration of remifentanil was used to provide fetal immobilization and analgesia. Fetal pathology included goiter and arthrogryposis, with one case requiring a tracheostomy. The longest time on placental circulation was 21 min. No clinically significant maternal sedation or respiratory depression was observed. In all cases, remifentanil provided adequate fetal immobilization and obviated the need to administer other analgesics or neuromuscular blocking agents. Remifentanil is a useful adjunct for ex utero fetal procedures.

Original languageEnglish (US)
Pages (from-to)851-855
Number of pages5
JournalBritish Journal of Anaesthesia
Issue number6
Publication statusPublished - Jun 2011
Externally publishedYes



  • anaesthesia, epidural
  • anaesthesia, spinal
  • remifentanil hydrochloride
  • therapy, fetal

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this